Brazil and Israel Added to EU API Approval List

[membership level=”0,4″][The content continues for paid members only.] Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership] The European Commission (EC) announced that Brazil and Israel have been added to its list of countries that may export active pharmaceutical ingredients (APIs) into the EU without an accompanying certificate of GMP compliance. Brazil and Israel join Australia, Japan, Switzerland, and the U.S. on the list of countries whose GMP compliance systems have been deemed equivalent to that of the EU member states and do not require certificates of GMP compliance to accompany individual batches of API.
[/membership]